Pioneering Research for Unique Conditions

At Novarrow, we are dedicated to advancing biomedical and pharmaceutical research specifically for rare hematologic, pediatric, and inherited diseases. Our team operates at the intersection of scientific research, preclinical development, and strategic clinical trial planning. By harnessing scientific expertise and fostering collaborative partnerships, we tackle the unique challenges of these complex conditions, ensuring that promising ideas transform into meaningful patient outcomes. Based in Cleveland, OH, we are committed to making a difference in the lives of those affected by rare diseases.

Meet Our Team

The People Behind Novarrow

Our team brings together scientific knowledge, research experience, and a commitment to improving the development of new approaches for patients living with rare and complex conditions.
We work collaboratively with researchers, clinicians, and other specialists to address challenging scientific questions and develop strategies that can help move research forward.

Maxim Rossmann

Founder

Structural biologist and biophysicist with 15+ years of experience in preclinical drug and peptide development. 

Maxim has 8 years of experience working with the recombinant eIF6 protein and ribosomes, including the development of biophysical assays, eIF6 crystallography, and NMR.

Christine Hilcenko

Founder

Protein chemist and structural biologist, NMR and Cryo-EM scientist with 20+ years of experience.

Christine has over 15 years of experience working with recombinant eIF6 protein and ribosomes, including biophysical assay, eIF6 crystallography and NMR.

Our Partners

We believe collaboration is essential to advancing rare disease research. We work with clinicians, researchers, and patient organizations to connect scientific research with the needs of patients and their families.

SDS patient charity, London

IP protection

Dr Jean Donadieu

Department of Hematology and Pediatric Oncology

Hospital Armand-Trousseau, Paris

Let’s work together to advance research and make a meaningful difference for patients with rare diseases.

 Get in Touch